Search - tctmd.com

Displaying 141 - 160 of 182

Sort: Relevancy | Date

ADAPT-TAVR: Edoxaban No Better Than DAPT After TAVI

News Conference News ACC 2022

ADAPT-TAVR: Edoxaban No Better Than DAPT After TAVI

April 05, 2022

Second-Generation Chocolate Touch DCB Bests Lutonix for Patency in PAD

News Conference News ACC 2022

Second-Generation Chocolate Touch DCB Bests Lutonix for Patency in PAD

April 04, 2022

Self-Expanding TAVI Looks More Durable Than SAVR at 5 Years

News Conference News ACC 2022

Self-Expanding TAVI Looks More Durable Than SAVR at 5 Years

Michael O'Riordan

April 04, 2022

COVID-19: TCTMD’s Dispatch for April Week 1

News Daily News

COVID-19: TCTMD’s Dispatch for April Week 1

April 04, 2022

APOLLO: Novel siRNA Injectable Cuts Lp(a) by Nearly 100% in Small Study

News Conference News ACC 2022

APOLLO: Novel siRNA Injectable Cuts Lp(a) by Nearly 100% in Small Study

Michael O'Riordan

April 03, 2022

CHAP: Better Blood Pressure Control, Better Pregnancy Outcomes

News Conference News ACC 2022

CHAP: Better Blood Pressure Control, Better Pregnancy Outcomes

Michael O'Riordan

April 02, 2022

Mavacamten Slashes Need for Septal Reduction in Obstructive HCM: VALOR-HCM

News Conference News ACC 2022

Mavacamten Slashes Need for Septal Reduction in Obstructive HCM: VALOR-HCM

Yael L. Maxwell

April 02, 2022

What’s Going to Be Hot at ACC 2022, In Person or Virtual

News Conference News ACC 2022

What’s Going to Be Hot at ACC 2022, In Person or Virtual

March 28, 2022

COVID-19: TCTMD’s Dispatch for March Week 5

News Daily News

COVID-19: TCTMD’s Dispatch for March Week 5

March 28, 2022

Early Aspirin Tied to Less In-Hospital Mortality in Moderate COVID-19

News Daily News

Early Aspirin Tied to Less In-Hospital Mortality in Moderate COVID-19

March 25, 2022

Surgical Societies Question VARC-3 Endpoints for Valve Disease Trials

News Daily News

Surgical Societies Question VARC-3 Endpoints for Valve Disease Trials

Michael O'Riordan

March 23, 2022

REMAP-CAP: Mixed Results for Antiplatelets in Critical COVID-19

News Daily News

REMAP-CAP: Mixed Results for Antiplatelets in Critical COVID-19

March 22, 2022

Postmarketing Studies of CV Devices Still Lacking in the US

News Daily News

Postmarketing Studies of CV Devices Still Lacking in the US

March 17, 2022

Radial Access for Angiography and PCI on the Rise in US

News Daily News

Radial Access for Angiography and PCI on the Rise in US

Michael O'Riordan

March 16, 2022

Antithrombotics Not Worth the Risk During Endovascular Stroke Therapy

News Daily News

Antithrombotics Not Worth the Risk During Endovascular Stroke Therapy

March 07, 2022

DISCHARGE Hailed as a Big Step Forward for CTA in Stable Chest Pain

News Daily News

DISCHARGE Hailed as a Big Step Forward for CTA in Stable Chest Pain

Michael O'Riordan

March 04, 2022

BIOFLOW V: Orsiro Still Offers Some Benefits at 5 Years

News Conference News

BIOFLOW V: Orsiro Still Offers Some Benefits at 5 Years

March 02, 2022

Longer-Term LRT Results ‘Encouraging’ for TAVI in Low-risk Patients

News Conference News

Longer-Term LRT Results ‘Encouraging’ for TAVI in Low-risk Patients

March 01, 2022

News Daily News

Skipping Low-Value Cardiovascular Care Could Save Billions: AHA

Michael O'Riordan

March 01, 2022

Recurrent Stroke Risk Lower With More Intense LDL-Lowering: Meta-analysis

News Daily News

Recurrent Stroke Risk Lower With More Intense LDL-Lowering: Meta-analysis

Yael L. Maxwell

March 01, 2022

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.